Limatoc, Ailene C.
HRN: 26-30-36 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/05/2024
CEFTAZIDIME 1GM (VIAL)
12/05/2024
12/12/2024
IV
2 Grams
Q 8hrs
Cap MR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes